Bouhatous, YM, Bredrup, C, Maurer, A, Mirakovska, L, Foster, A, Kosaki, K, Jost, C, Demoulin, JB, Luu, M, Vabres, P, Kurtz, JE, Schaefer, E, Guimier, A, Cormier-Daire, V, Lim, D, Thompson, S, Olson, L, Kwon, HR, Aguirre-Rodriguez, C, Hernandez-Dorronsoro, U, Martinez-Soroa, I, Iznardo, H, Mascaro, JMJ, Baselga, E, Kalantari, S, Mussa, A, Gazzin, A, Carli, D, Svinvik, I, Mutlu-Albayrak, H, Bluefeather, S, Zarate, Y, Takenouchi, T, Naicker, T, Chateau, A, Gokhul, A, Dube-Pule, A, Haniffa, M, Peitee, WO, Nordgren, A, Carpentier, M, Binquet, C, Briffaut, AS, Bal, L, Pond, D, Rustad, CF, Bardou, M, Faivre, L. 'Knowing and Treating Kosaki/Penttinen syndrome' international collaborative consortium: recommendations for follow-up, natural history and a real-life observational study about safety and efficacy profile of tyrosine kinase inhibitors. JOURNAL OF MEDICAL GENETICS. 2025; 62(10)DOI:10.1136/jmg-2024-110600. PMID:40707250. IF:3.700(Q2/3D).

Yosipovitch, G, Lio, PA, Rosmarin, D, Legat, FJ, Serra-Baldrich, E, Carrascosa, JM, Bardolet, L, Crane, H, Casillas, M, Pierce, E, Zhong, JL, Elmaraghy, H, Ständer, S. Lebrikizumab Improved Itch Symptoms and Reduced Itch Interference on Sleep over 52 Weeks in Patients with Moderate-to-Severe Atopic Dermatitis in Two Phase 3 Trials. DERMATOLOGY. 2025; 241(4)DOI:10.1159/000547142. PMID:40602386. IF:2.700(Q2/4D).

Slusarczyk, A, Scilipoti, P, Contieri, R, Longoni, M, de Angelis, M, Miszczyk, M, Krajewski, W, Laukthina, E, Del Giudice, F, Gallioli, A, Rajwa, P, Pradere, B, Shah, PR, Boorjian, SA, Moschini, M, Radziszewski, P. Comparative Assessment of Chemotherapy Followed by Consolidative Radical Cystectomy Versus Chemoradiation for Clinically Node-Positive Urothelial Carcinoma of the Bladder. Clinical Genitourinary Cancer. 2025; 23(5)DOI:10.1016/j.clgc.2025.102399. PMID:40737768. IF:2.700(Q2/3D).

Gallioli, A, Di Bello, F, Breda, A. Telesurgery in urology - advances, challenges and future directions. Nature Reviews Urology. 2025; 22(10)DOI:10.1038/s41585-025-01045-3. PMID:40404860. IF:14.600(Q1/1D).